ALLIANCE A222004

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Brain, Brain Metastatic, Breast, Breast Metastatic, Carcinoid Metastatic, Cervical Metastatic, Colon Metastatic, Endometrial Metastatic, Esophageal Metastatic, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck Metastatic, Lung, Lung - Non-Small Cell Metastatic, Metastatic Melanoma, Neuroendocrine, Pancreatic Metastatic, Prostate Metastatic, Rectal Metastatic, Renal Metastatic, Skin, Stomach Metastatic

Status:

New, Open

A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

NCT#04939090

Site staff should complete the information required on Site Activation Form (Click Here) and submit it to the Alliance Pharmaceutical Affairs Manager at pharmaffairs@alliancenctn.org, along with a copy of the site’s pharmacy or physician license.